See more : Talkspace, Inc. (TALKW) Income Statement Analysis – Financial Results
Complete financial analysis of Krsnaa Diagnostics Limited (KRSNAA.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Krsnaa Diagnostics Limited, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Opsens Inc. (OPS.TO) Income Statement Analysis – Financial Results
- A.P. Møller – Mærsk A/S (0O77.IL) Income Statement Analysis – Financial Results
- Incitec Pivot Limited (ICPVF) Income Statement Analysis – Financial Results
- DelphX Capital Markets Inc. (DELX.V) Income Statement Analysis – Financial Results
- Nippon Kanzai Co., Ltd. (9728.T) Income Statement Analysis – Financial Results
Krsnaa Diagnostics Limited (KRSNAA.BO)
About Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited provides diagnostic services. The company offers a range of technology-enabled diagnostic services, such as radiology, pathology/clinical laboratory, and tele-radiology services to public and private hospitals, medical colleges, and community health centers. It operates through a network of approximately 2,850 centers across 15 states and 2 Union Territories in India. The company was incorporated in 2010 and is based in Pune, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 6.20B | 4.87B | 4.55B | 3.96B | 2.58B | 2.09B | 1.08B | 568.90M |
Cost of Revenue | 3.93B | 1.55B | 1.68B | 1.92B | 1.03B | 796.60M | 764.64M | 148.73M |
Gross Profit | 2.27B | 3.32B | 2.87B | 2.05B | 1.55B | 1.30B | 311.06M | 420.16M |
Gross Profit Ratio | 36.65% | 68.10% | 63.05% | 51.58% | 60.04% | 61.93% | 28.92% | 73.86% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 654.68M | 81.49M | 64.42M | 107.88M | 65.78M | 52.34M | 175.05M | 124.97M |
Selling & Marketing | 29.36M | 31.91M | 18.09M | 10.33M | 12.46M | 7.89M | 3.32M | 4.69M |
SG&A | 1.57B | 113.40M | 82.51M | 118.21M | 78.24M | 60.23M | 161.67M | 129.66M |
Other Expenses | 0.00 | 3.59M | 20.00K | 110.00K | 2.13M | 920.00K | -2.55M | 0.00 |
Operating Expenses | 1.57B | 2.62B | 1.97B | 1.48B | 1.25B | 972.93M | 164.22M | 360.50M |
Cost & Expenses | 5.48B | 4.18B | 3.65B | 3.40B | 2.28B | 1.77B | 928.86M | 509.23M |
Interest Income | 167.59M | 181.24M | 149.09M | 122.25M | 127.27M | 49.80M | 23.77M | 37.15M |
Interest Expense | 164.88M | 64.35M | 168.63M | 249.27M | 231.87M | 159.50M | 80.25M | 0.00 |
Depreciation & Amortization | 745.47M | 537.82M | 413.87M | 374.39M | 324.11M | 256.40M | 175.08M | 98.21M |
EBITDA | 1.61B | 1.42B | 1.46B | 3.59B | -1.01B | -325.17M | 321.92M | 144.81M |
EBITDA Ratio | 25.99% | 28.79% | 31.84% | 26.62% | 28.75% | 28.38% | 29.93% | 25.45% |
Operating Income | 696.99M | 702.64M | 909.03M | 575.49M | 304.11M | 322.82M | 146.84M | 46.60M |
Operating Income Ratio | 11.25% | 14.42% | 19.96% | 14.52% | 11.77% | 15.43% | 13.65% | 8.19% |
Total Other Income/Expenses | 3.08M | -1.49B | -1.21B | 1.40B | -1.89B | -1.10B | -989.65M | -24.09M |
Income Before Tax | 700.07M | 802.01M | 865.08M | 2.95B | -1.58B | -777.26M | -842.81M | 22.52M |
Income Before Tax Ratio | 11.30% | 16.46% | 18.99% | 74.52% | -61.27% | -37.15% | -78.35% | 3.96% |
Income Tax Expense | 131.70M | 180.90M | 181.20M | 1.11B | -463.81M | -196.69M | -241.24M | 1.79M |
Net Income | 568.37M | 621.11M | 683.88M | 1.85B | -1.12B | -580.57M | -601.57M | -39.25M |
Net Income Ratio | 9.17% | 12.75% | 15.02% | 46.65% | -43.32% | -27.75% | -55.92% | -6.90% |
EPS | 17.90 | 19.78 | 22.89 | 160.36 | -35.66 | -18.49 | -58.27 | -3.80 |
EPS Diluted | 17.31 | 19.29 | 22.88 | 71.86 | -34.80 | -18.49 | -58.27 | -3.80 |
Weighted Avg Shares Out | 31.75M | 31.40M | 31.40M | 31.40M | 31.40M | 31.40M | 10.32M | 10.32M |
Weighted Avg Shares Out (Dil) | 32.84M | 32.20M | 32.17M | 32.17M | 32.17M | 31.40M | 10.32M | 10.32M |
Source: https://incomestatements.info
Category: Stock Reports